The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1038/s41386-018-0136-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- Intracellular Signaling Pathways Involved in ( S )- and ( R )-Ketamine Antidepressant Actions
- (2018) Panos Zanos et al. BIOLOGICAL PSYCHIATRY
- Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine
- (2018) Sriparna Ghosal et al. BIOLOGICAL PSYCHIATRY
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- Comparison of direct 13 C and indirect 1 H-[ 13 C] MR detection methods for the study of dynamic metabolic turnover in the human brain
- (2017) Hao Chen et al. JOURNAL OF MAGNETIC RESONANCE
- Selective proton-observed, carbon-edited (selPOCE) MRS method for measurement of glutamate and glutamine 13 C-labeling in the human frontal cortex
- (2017) Henk M. De Feyter et al. MAGNETIC RESONANCE IN MEDICINE
- Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression
- (2017) I Esterlis et al. MOLECULAR PSYCHIATRY
- Targeting glutamate signalling in depression: progress and prospects
- (2017) James W. Murrough et al. NATURE REVIEWS DRUG DISCOVERY
- ACNP 56th Annual Meeting: Poster Session I, December 4, 2017
- (2017) NEUROPSYCHOPHARMACOLOGY
- Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder
- (2017) Dustin Scheinost et al. NEUROPSYCHOPHARMACOLOGY
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder
- (2016) James W. Murrough et al. HUMAN BRAIN MAPPING
- GABA interneurons mediate the rapid antidepressant-like effects of scopolamine
- (2016) Eric S. Wohleb et al. JOURNAL OF CLINICAL INVESTIGATION
- Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
- (2016) G M I Chowdhury et al. MOLECULAR PSYCHIATRY
- Ketamine Treatment and Global Brain Connectivity in Major Depression
- (2016) Chadi G Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
- (2015) Alan Anticevic et al. BIOLOGICAL PSYCHIATRY
- In Vivo Ketamine-Induced Changes in [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5
- (2015) Christine DeLorenzo et al. BIOLOGICAL PSYCHIATRY
- A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
- (2015) M S Milak et al. MOLECULAR PSYCHIATRY
- Glutamate Metabolism in Major Depressive Disorder
- (2014) Chadi G. Abdallah et al. AMERICAN JOURNAL OF PSYCHIATRY
- Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
- (2013) Bhavya Voleti et al. BIOLOGICAL PSYCHIATRY
- Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
- (2013) N R Driesen et al. MOLECULAR PSYCHIATRY
- The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity
- (2013) Naomi R Driesen et al. NEUROPSYCHOPHARMACOLOGY
- Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels
- (2013) Fahmeed Hyder et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
- (2012) J M Stone et al. MOLECULAR PSYCHIATRY
- NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
- (2012) A. Anticevic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
- (2012) D. C. Javitt et al. SCHIZOPHRENIA BULLETIN
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- Glutamatergic Modulation of Auditory Information Processing in the Human Brain
- (2011) Handan Gunduz-Bruce et al. BIOLOGICAL PSYCHIATRY
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism
- (2011) Golam M.I. Chowdhury et al. BIOLOGICAL PSYCHIATRY
- Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study
- (2011) Matthew J Taylor et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence
- (2011) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide
- (2011) Robin A. de Graaf et al. NMR IN BIOMEDICINE
- 13C MRS studies of neuroenergetics and neurotransmitter cycling in humans
- (2011) Douglas L. Rothman et al. NMR IN BIOMEDICINE
- Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
- (2010) John H. Krystal et al. CNS DRUGS
- 13C MRS of occipital and frontal lobes at 3 T using a volume coil for stochastic proton decoupling
- (2010) Shizhe Li et al. NMR IN BIOMEDICINE
- In vivo13C magnetic resonance spectroscopy of human brain on a clinical 3 T scanner using [2-13C]glucose infusion and low-power stochastic decoupling
- (2009) Shizhe Li et al. MAGNETIC RESONANCE IN MEDICINE
- Glutamate and the Neural Basis of the Subjective Effects of Ketamine
- (2008) J. F. William Deakin et al. ARCHIVES OF GENERAL PSYCHIATRY
- Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe
- (2008) Napapon Sailasuta et al. JOURNAL OF MAGNETIC RESONANCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now